ReviewFrontiers in oncology2017

Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Varda Shoshan-Barmatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.